TransMedics Group Inc.

NASDAQ: TMDX · Real-Time Price · USD
127.08
-2.66 (-2.05%)
At close: Aug 15, 2025, 12:16 PM

TransMedics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
441.54M 241.62M 93.46M 30.26M
Cost of Revenue
179.46M 87.53M 28.19M 9.1M
Gross Profit
262.08M 154.09M 65.27M 21.16M
Operating Income
37.5M -28.73M -31.44M -39.43M
Interest Income
n/a 12.5M 900K n/a
Pretax Income
35.78M -26.67M -36.16M -44.18M
Net Income
35.46M -25.03M -36.23M -44.22M
Selling & General & Admin
168.62M 119.55M 69.9M 38.28M
Research & Development
55.97M 63.27M 26.81M 22.3M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
224.59M 182.82M 96.71M 60.59M
Interest Expense
14.41M 10.79M 3.73M 3.87M
Selling & Marketing Expenses
n/a n/a 18.21M n/a
Cost & Expenses
404.04M 270.35M 124.9M 69.69M
Income Tax Expense
316K -1.64M 66K 36K
Shares Outstanding (Basic)
33.23M 32.52M 29.56M 27.62M
Shares Outstanding (Diluted)
35.22M 32.52M 29.56M 27.62M
EPS (Basic)
1.07 -0.77 -1.23 -1.6
EPS (Diluted)
1.01 -0.77 -1.23 -1.6
EBITDA
69.95M -7.6M -28.96M -38.49M
EBIT
50.19M -15.88M -32.44M -40.3M
Depreciation & Amortization
19.76M 8.18M 4.2M 2.65M